Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rheinstein

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
In Vivo (Athens, Greece)|January 2, 2026
FOXA1 Alterations in Prostate Cancer: Expression, Mutation Classes, and Copy Number ChangesSteven Lehrer, Peter Rheinstein
In Vivo (Athens, Greece)|April 29, 2021
Eyeglasses Reduce Risk of COVID-19 InfectionSteven Lehrer, Peter Rheinstein
Clinical Neuropharmacology|January 13, 2026
RAP1A Variant rs7525578 Modifies Glycemic Response to Metformin But Not to Pioglitazone or Gliclazide in the UK BiobankSteven Lehrer, Peter Rheinstein
Clinical Parkinsonism & Related Disorders|September 22, 2025
SNP rs7549881, near SGIP1 at 1p31.3, is significantly associated with digestive disorders and Parkinsonism in womenSteven Lehrer, Peter Rheinstein
Research Square|May 3, 2024
rs140926439 variant in the Fibronectin FN1 gene protects against Alzheimer's disease in APOEε4 carriers in the UK Biobank cohortSteven Lehrer, Peter Rheinstein
American Journal of Clinical Oncology|April 23, 2025
Long-Lasting Cigarette Smoking Alterations in Immune Function Occur in Cannabis Smokers, Possibly Rendering Them Vulnerable to Smoking-Related Tumors in Later LifeSteven Lehrer, Peter Rheinstein
American Journal of Alzheimer'S Disease and Other Dementias|December 26, 2015
Relation of Poor Memory to Soluble Tumor Necrosis Factor Receptor Type Two (sTNF-RII)Steven Lehrer, Peter Rheinstein
American Journal of Clinical Oncology|July 8, 2026
Targeted CysLTR1 Blockade Rescues Myeloid-Mediated Resistance to Immune Checkpoint Inhibition in Solid Malignancies: A Combined Genomic, Emulated Clinical Trial, and Epidemiological Negative-Control AnalysisSteven Lehrer, Peter Rheinstein
Cancer Diagnosis & Prognosis|July 2, 2026
<i>CDKN2A</i> mRNA Over-expression Is Associated With CD8+ T Cell Exclusion and IDO1-Mediated Adaptive Immune Resistance in Gastric AdenocarcinomaSteven Lehrer, Peter Rheinstein
Research Square|August 16, 2024
The paired immunoglobulin-like type 2 receptor alpha (PILRA) gene polymorphism rs1859788 reduces risk of Alzheimer's Disease in men homozygous for the ApoE ε4 alleleSteven Lehrer, Peter Rheinstein
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
In Vivo (Athens, Greece)|January 2, 2026
FOXA1 Alterations in Prostate Cancer: Expression, Mutation Classes, and Copy Number ChangesSteven Lehrer, Peter Rheinstein
In Vivo (Athens, Greece)|April 29, 2021
Eyeglasses Reduce Risk of COVID-19 InfectionSteven Lehrer, Peter Rheinstein
Clinical Neuropharmacology|January 13, 2026
RAP1A Variant rs7525578 Modifies Glycemic Response to Metformin But Not to Pioglitazone or Gliclazide in the UK BiobankSteven Lehrer, Peter Rheinstein
Clinical Parkinsonism & Related Disorders|September 22, 2025
SNP rs7549881, near SGIP1 at 1p31.3, is significantly associated with digestive disorders and Parkinsonism in womenSteven Lehrer, Peter Rheinstein
Research Square|May 3, 2024
rs140926439 variant in the Fibronectin FN1 gene protects against Alzheimer's disease in APOEε4 carriers in the UK Biobank cohortSteven Lehrer, Peter Rheinstein
American Journal of Clinical Oncology|April 23, 2025
Long-Lasting Cigarette Smoking Alterations in Immune Function Occur in Cannabis Smokers, Possibly Rendering Them Vulnerable to Smoking-Related Tumors in Later LifeSteven Lehrer, Peter Rheinstein
American Journal of Alzheimer'S Disease and Other Dementias|December 26, 2015
Relation of Poor Memory to Soluble Tumor Necrosis Factor Receptor Type Two (sTNF-RII)Steven Lehrer, Peter Rheinstein
American Journal of Clinical Oncology|July 8, 2026
Targeted CysLTR1 Blockade Rescues Myeloid-Mediated Resistance to Immune Checkpoint Inhibition in Solid Malignancies: A Combined Genomic, Emulated Clinical Trial, and Epidemiological Negative-Control AnalysisSteven Lehrer, Peter Rheinstein
Cancer Diagnosis & Prognosis|July 2, 2026
<i>CDKN2A</i> mRNA Over-expression Is Associated With CD8+ T Cell Exclusion and IDO1-Mediated Adaptive Immune Resistance in Gastric AdenocarcinomaSteven Lehrer, Peter Rheinstein
Research Square|August 16, 2024
The paired immunoglobulin-like type 2 receptor alpha (PILRA) gene polymorphism rs1859788 reduces risk of Alzheimer's Disease in men homozygous for the ApoE ε4 alleleSteven Lehrer, Peter Rheinstein
Pageof 1